Login
Thermo Fisher Scientific reported adjusted earnings of $6.68 per share, up 15%
21 October 2026 at 15:00
Revenue grew 9% to $12.14 billion, and the company said it would give updated 2026 guidance on its Wednesday morning call
Normal view
HHS is pushing to open up the U.S. dialysis market with a new kidney care plan
21 October 2026 at 13:50
The plan targets a dialysis market where DaVita and Fresenius hold a combined share near 74%, according to Axios
Abbott plans to spin off nutrition unit that generates $8.5 billion in annual sales
21 October 2026 at 13:50
The separation of the maker of Similac and Ensure is expected by the end of 2027 and will leave 2026 guidance unchanged
